$39.00
USD
Research Use Only (RUO) • Not for Human or Veterinary Use • Not for Consumption.
CJC-1295 with DAC is a specialized synthetic analog of Growth Hormone–Releasing Hormone (GHRH), engineered with a Drug Affinity Complex (DAC) to support extended stability in controlled laboratory environments. This peptide is prepared exclusively for in-vitro research, analytical studies, and experimental model development.
At Peptides Skin, we supply research-grade CJC-1295 with DAC (>99% purity), produced under stringent quality standards to ensure consistency and reproducibility across scientific workflows.
CJC-1295 is a tetrasubstituted 30-amino-acid peptide analog. The integration of the Drug Affinity Complex (DAC) is designed to support enhanced stability during laboratory handling and in-vitro analysis. This modification helps protect the peptide from rapid breakdown in experimental environments, enabling extended observation intervals during research protocols.
| Parameter | Specification |
|---|---|
| Peptide Name | CJC-1295 with DAC |
| Synonyms | DAC:GRF, Drug Affinity Complex GHRH |
| Molecular Formula | C165H269N47O46 |
| Molecular Weight | 3647.28 g/mol |
| Sequence | Peptide sequence provided for reference in laboratory analysis. |
| Appearance | Sterile Filtered White Lyophilized Powder |
The Drug Affinity Complex is a chemical linker added to the peptide structure to support enhanced stability during laboratory workflows. This modification is designed to reduce rapid enzymatic breakdown commonly observed with unmodified GHRH analogs in research settings, enabling extended intervals for analytical observation.
Researchers often compare the DAC-modified version with the shorter-fragment analog (Mod GRF 1-29). The primary distinction lies in stability during laboratory analysis:
CJC-1295 with DAC is frequently utilized in controlled laboratory research focused on:
To maintain integrity during research workflows:
CJC-1295 with DAC includes a stability-enhancing linker designed for extended laboratory studies, while Mod GRF 1-29 is suited for short-duration research due to its rapid breakdown in vitro.
Lyophilized powder should be kept at −20°C. After reconstitution, store at 4°C and avoid freeze–thaw cycles to maintain structural integrity.
The DAC linker supports enhanced stability during laboratory workflows by reducing susceptibility to enzymatic degradation in research environments.
No. It is strictly for laboratory and in-vitro research purposes only.